Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,007 DKK | -2.04% |
|
+2.32% | +44.25% |
08:45am | NOVO NORDISK : Goldman Sachs reiterates its Buy rating | ZD |
06-26 | 2seventy bio Sells Hemophilia A Candidate, Gene Editing Technology to Novo Nordisk; Shares Rise After Hours | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.25% | 640B | |
+54.61% | 811B | |
-6.33% | 353B | |
+20.62% | 333B | |
+10.44% | 302B | |
+18.45% | 246B | |
+2.09% | 225B | |
+13.03% | 218B | |
+8.61% | 168B | |
-4.76% | 155B |
- Stock Market
- Equities
- NOVO B Stock
- News Novo Nordisk A/S
- Novo Nordisk site in Denmark hit by fire, spokesperson says